Ubs Asset Management Americas Inc Care Dx, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 140,919 shares of CDNA stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,919
Previous 274,688
48.7%
Holding current value
$2.25 Million
Previous $5.37 Million
61.84%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CDNA
# of Institutions
200Shares Held
54.5MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.75MShares$59.8 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...